Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -278,961 | -135,643 | -526,244 | -389,348 | -259,926 |
| Depreciation Amortization | 4,737 | 2,331 | 11,892 | 5,557 | 3,703 |
| Accounts receivable | 1,283 | 449 | -1,136 | -2,352 | -838 |
| Accounts payable and accrued liabilities | -12,105 | -10,294 | -3,483 | -11,194 | -12,429 |
| Other Working Capital | -15,934 | -25,701 | 3,089 | -41,790 | -43,271 |
| Other Operating Activity | 72,160 | 39,351 | 101,549 | 98,831 | 68,670 |
| Operating Cash Flow | $-228,820 | $-129,507 | $-414,333 | $-340,296 | $-244,091 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,915 | N/A | -1,416 | -1,339 | -1,119 |
| Purchase Of Investment | -957,890 | -142,655 | -635,211 | -409,096 | -291,371 |
| Sale Of Investment | 340,898 | 175,296 | 875,880 | 731,099 | 540,115 |
| Investing Cash Flow | $-618,907 | $32,641 | $239,253 | $320,664 | $247,625 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,810 | -932 | -858 | -636 | -419 |
| Common Stock Issued | N/A | 123,172 | 164,233 | N/A | 9,234 |
| Other Financing Activity | 928,612 | -18,449 | 57,942 | 53,153 | -10,517 |
| Financing Cash Flow | $924,802 | $103,791 | $221,317 | $52,517 | $-1,702 |
| Exchange Rate Effect | 43 | 27 | -20 | N/A | N/A |
| Beginning Cash Position | 113,399 | 113,399 | 67,182 | 67,182 | 67,182 |
| End Cash Position | 190,517 | 120,351 | 113,399 | 100,067 | 69,014 |
| Net Cash Flow | $77,118 | $6,952 | $46,217 | $32,885 | $1,832 |
| Free Cash Flow | |||||
| Operating Cash Flow | -228,820 | -129,507 | -414,333 | -340,296 | -244,091 |
| Capital Expenditure | -1,915 | N/A | -1,416 | -1,339 | -1,119 |
| Free Cash Flow | -230,735 | -129,507 | -415,749 | -341,635 | -245,210 |